Detalles de la búsqueda
1.
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Gastric Cancer;
24(4): 926-936, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651195
2.
Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
Ann Surg Oncol;
26(9): 2805-2811, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209673
3.
ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases.
Ann Surg Oncol;
26(Suppl 3): 842, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31659641
4.
State of the scientific evidence and recommendations for the management of older patients with gastric cancer.
J Geriatr Oncol;
15(3): 101657, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957106
5.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Clin Transl Oncol;
2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361134
6.
Current developments in gastric cancer: from molecular profiling to treatment strategy.
Nat Rev Gastroenterol Hepatol;
20(3): 155-170, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344677
7.
State of the Art: ctDNA in Upper Gastrointestinal Malignancies.
Cancers (Basel);
15(5)2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900172
8.
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Cancers (Basel);
15(5)2023 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900420
9.
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.
Head Neck;
45(12): 3075-3085, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792371
10.
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective.
Cancers (Basel);
16(1)2023 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201577
11.
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Cancers (Basel);
15(14)2023 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509217
12.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol;
15: 17588359231157641, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895850
13.
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
J Cancer Res Clin Oncol;
149(7): 4077-4089, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36042046
14.
SEOM-TTCC clinical guideline in nasopharynx cancer (2021).
Clin Transl Oncol;
24(4): 670-680, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303267
15.
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study.
Front Pharmacol;
13: 894550, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35721217
16.
Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma.
Cancers (Basel);
14(23)2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497475
17.
Gastric perforation related to a transgastric biliary drainage procedure with endoscopic Rendez-Vous technique.
Rev Gastroenterol Mex;
76(4): 389-92, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22188969
18.
Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain.
Front Oncol;
11: 747520, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141139
19.
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma.
Front Med (Lausanne);
8: 720128, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34869418
20.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Ther Adv Med Oncol;
13: 17588359211019672, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211587